Home
NICE Guidance
Conditions and diseases
Eye conditions
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Technology appraisal guidance [TA155]
Published:
27 August 2008
Last updated:
01 May 2012
Guidance
Tools and resources
Information for the public
History
Do no do examples
Do no do examples for Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Title
Year published
Impact Level
No results could be found